Evidence map›Paper›PMID 26286636›Full record

ReviewIranian biomedical journal2016

Toxicity of Nanoparticles and an Overview of Current Experimental Models.

Haji Bahadar, Faheem Maqbool, Kamal Niaz, Mohammad Abdollahi

Abstract readReview
In one paragraph

Review in Iranian biomedical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 215 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
215citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

215 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Dissolution Enhancement of Lycopene Compacts by Liquisolid Technique.Turkish journal of pharmaceutical sciences · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. PrNanomaterials (Basel, Switzerland) · 2025
    Review

155 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Haji BahadarDept. of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
Faheem MaqboolDept. of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
Kamal NiazDept. of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad AbdollahiDept. of Toxicology and Pharmacology, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, International Campus, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology is a rapidly growing field having potential applications in many areas. Nanoparticles (NPs) have been studied for cell toxicity, immunotoxicity, and genotoxicity. Tetrazolium-based assays such as MTT, MTS, and WST-1 are used to determine cell viability. Cell inflammatory response induced by NPs is checked by measuring inflammatory biomarkers, such as IL-8, IL-6, and tumor necrosis factor, using ELISA. Lactate dehydrogenase (LDH) assay is used for cell membrane integrity. Different types of cell cultures, including cancer cell lines have been employed as in vitro toxicity models. It has been generally agreed that NPs interfere with either assay materials or with detection systems. So far, toxicity data generated by employing such models are conflicting and inconsistent. Therefore, on the basis of available experimental models, it may be difficult to judge and list some of the more valuable NPs as more toxic to biological systems and vice versa. Considering the potential applications of NPs in many fields and the growing apprehensions of FDA about the toxic potential of nanoproducts, it is the need of the hour to look for new internationally agreed free of bias toxicological models by focusing more on in vivo studies.

Indexed as

AnimalsCell LineCell SurvivalDNA DamageHumansMetal NanoparticlesNanostructuresNanotechnologyCytotoxicityin vitroMetal nanoparticlesReviewToxicology

Identifiers

PMID26286636
PMCPMC4689276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.